[HTML][HTML] Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
A Gupta, A Konnova, M Smet, M Berkell… - The Journal of …, 2023 - Am Soc Clin Investig
Background The role of host immunity in emergence of evasive SARS-CoV-2 Spike
mutations under therapeutic monoclonal antibody (mAb) pressure remains to be explored …
mutations under therapeutic monoclonal antibody (mAb) pressure remains to be explored …
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
A Gupta, A Konnova, M Smet… - The journal of …, 2023 - repository.uantwerpen.be
The role of host immunity in emergence of evasive SARS-CoV-2 Spike mutations under
therapeutic monoclonal antibody (mAb) pressure remains to be explored. Here, we show …
therapeutic monoclonal antibody (mAb) pressure remains to be explored. Here, we show …
[HTML][HTML] Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
A Gupta, A Konnova, M Smet, M Berkell, A Savoldi… - 2022 - europepmc.org
The role of host immunity in emergence of evasive SARS-CoV-2 Spike mutations under
therapeutic monoclonal antibody (mAb) pressure remains to be explored. Here, we show …
therapeutic monoclonal antibody (mAb) pressure remains to be explored. Here, we show …
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
A Gupta, A Konnova, M Smet, M Berkell… - Journal of Clinical …, 2023 - search.proquest.com
BACKGROUND. The role of host immunity in emergence of evasive SARS-CoV-2 Spike
mutations under therapeutic monoclonal antibody (mAb) pressure remains to be explored …
mutations under therapeutic monoclonal antibody (mAb) pressure remains to be explored …
[PDF][PDF] Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
A Gupta, A Konnova, M Smet, M Berkell, A Savoldi… - scholar.archive.org
The role of host immunity in emergence of evasive SARS-CoV-2 Spike mutations under
therapeutic monoclonal antibody (mAb) pressure remains to be explored. Here, we show …
therapeutic monoclonal antibody (mAb) pressure remains to be explored. Here, we show …
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
A Gupta, A Konnova, M Smet… - The Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
BackgroundThe role of host immunity in emergence of evasive SARS-CoV-2 Spike
mutations under therapeutic monoclonal antibody (mAb) pressure remains to be explored …
mutations under therapeutic monoclonal antibody (mAb) pressure remains to be explored …
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
A Gupta, A Konnova, M Smet, M Berkell, A Savoldi… - medRxiv, 2022 - medrxiv.org
The role of host immunity in emergence of evasive SARS-CoV-2 Spike mutations under
therapeutic monoclonal antibody (mAb) pressure remains to be explored. Here, we show …
therapeutic monoclonal antibody (mAb) pressure remains to be explored. Here, we show …
[HTML][HTML] Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
A Gupta, A Konnova, M Smet, M Berkell… - The Journal of …, 2023 - ncbi.nlm.nih.gov
Background The role of host immunity in emergence of evasive SARS-CoV-2 Spike
mutations under therapeutic monoclonal antibody (mAb) pressure remains to be explored …
mutations under therapeutic monoclonal antibody (mAb) pressure remains to be explored …
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments.
A Gupta, A Konnova, M Smet, M Berkell, A Savoldi… - 2023 - cabidigitallibrary.org
Background: The role of host immunity in emergence of evasive SARS-CoV-2 Spike
mutations under therapeutic monoclonal antibody (mAb) pressure remains to be explored …
mutations under therapeutic monoclonal antibody (mAb) pressure remains to be explored …
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
A Gupta, A Konnova, M Smet, M Berkell… - THE JOURNAL OF …, 2023 - iris.univr.it
Background: The role of host immunity in emergence of evasive SARS-CoV-2 Spike
mutations under therapeutic monoclonal antibody (mAb) pressure remains to be explored …
mutations under therapeutic monoclonal antibody (mAb) pressure remains to be explored …